2017
DOI: 10.1097/gco.0000000000000372
|View full text |Cite
|
Sign up to set email alerts
|

The sticky business of adhesion prevention in minimally invasive gynecologic surgery

Abstract: There is great interest in new adhesion prevention technologies, but new agents are unlikely to be available for clinical use for many years. High-quality effectiveness and outcomes-related research is still needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
26
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(26 citation statements)
references
References 82 publications
0
26
0
Order By: Relevance
“…Second, there is a method of suppressing adhesion using drugs based on the mechanism of adhesion [ 128 ]. Finally, there is a method of minimizing adhesion by unnecessary tissue damage by using delicate surgery and minimally invasive surgery [ 129 ]. However, whilst minimally invasive surgical techniques can help to prevent adhesion to a level that minimizes or prevents exposure to foreign substances and tissue drying, there is the limitation that adhesion cannot be eliminated.…”
Section: Various Strategies Of Anti-adhesionmentioning
confidence: 99%
“…Second, there is a method of suppressing adhesion using drugs based on the mechanism of adhesion [ 128 ]. Finally, there is a method of minimizing adhesion by unnecessary tissue damage by using delicate surgery and minimally invasive surgery [ 129 ]. However, whilst minimally invasive surgical techniques can help to prevent adhesion to a level that minimizes or prevents exposure to foreign substances and tissue drying, there is the limitation that adhesion cannot be eliminated.…”
Section: Various Strategies Of Anti-adhesionmentioning
confidence: 99%
“…There is great interest in new adhesion prevention technologies [28]. In order to evaluate the risk of toxic effects of prophylactic agents, we suggest the use of multiple tests using blood and urine specimens, not only to detect changes in the systemic inflammatory response, but also to assess the possibility of clinically important adverse effects on the renal, hepatic and hematopoietic systems.…”
Section: Recommendationsmentioning
confidence: 99%
“…A strong deterrent for using a solid adhesion barrier in patients with metabolic syndrome and therefore a proinflammatory state is the risk for rejection. There is, however, no real proof of the clinical benefit of flowable/liquid adhesion barriers over saline or other crystalloid solutions [34,35]. A different approach towards adhesion prevention is to attempt to use existing and approved pharmacological agents such as steroids [36,37] , and systemically applied antibiotic treatment [38,39].…”
Section: How Can We Better Manage Surgical Adhesion Prophylaxis In Pamentioning
confidence: 99%